Comunicaciones de ESTUDIOS ENEIDA aceptados para UEGW18

Orales

Efficacy and safety of the sequential use of a second and third anti-TNF drug in patients with inflammatory bowel disease
María José Casanova. Hospital Universitario de La Princesa

Clinical differential characteristics of patients with inflammatory bowel disease (IBD) of onset in pediatric age compared to patients diagnosed in adulthood (CAROUSEL Study)
María Chaparro. Hospital Universitario de La Princesa

Effectiveness and safety of Vedolizumab in Inflammatory Bowel Diseases (Vedo – IT)
María Chaparro. Hospital Universitario de La Princesa

Pósters de estudios promovidos por GETECCU aceptados para UEGW18

Epidemiology, diagnostic work-up and pharmacological treatments of inflammatory bowel disease in Spain: results from the nationwide EpidemIBD study of GETECCU
María Chaparro. Hospital Universitario de La Princesa

Surgical and hospital admission in adults newly diagnosed with inflammatory bowel disease in the biological era in Spain: results of the nationwide EpidemIBD study of GETECCU
María Chaparro. Hospital Universitario de La Princesa